Buch, Englisch, 376 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 840 g
Buch, Englisch, 376 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 840 g
ISBN: 978-0-12-006695-7
Verlag: William Andrew Publishing
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
Zielgruppe
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
NY-ESO-1: Review of an Immunogenic Tumor Antigen.
Order, Disorder, Death: Lessons from a Superorganism.
Control of Differentiation in Progression of Epithelial Tumors.
Cancer Vaccines: Preclinical Studies and Novel Strategies.
Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.
Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.
NK Cell Receptors as Tools in Cancer Immunotherapy.
Innate Immune Recognition and Suppression of Tumors.
Inhibitors of the HSP90 Molecular Chaperone: Current Status.
